SEC 13F Intelligence

Carlson Capital, L.P. / XLRN

Carlson Capital, L.P.’s Acceleron Pharma Inc Position

Does Carlson Capital, L.P. own Acceleron Pharma Inc (XLRN)? Not currently — the last reported position was 80.0K shares worth $14M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$14M
Q3 2021
Shares
80.0K
% of Portfolio
+0.73%
Quarters Held
1
position exited

Position History XLRN

Reported value by quarter
Q3 ’21: $14MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202180.0K$14M+0.73%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Carlson Capital, L.P.’s full portfolio or all institutional holders of XLRN.